GREY:BITKF - Post by User
Post by
tickle1ston May 03, 2011 8:07am
606 Views
Post# 18521352
News-Key Points
News-Key PointsIn 2010, Biosign received clearance in the European Union to market anapplication for online measurement of blood pressure and blood glucose.
The company plans to seek market clearance for its medical devices inthe United States as soon as the changes to the FDA's medical deviceclearance program become effective.
As of December 31, 2010, Biosign had cash and cash equivalents of almost$3 million, an increase of over $2 million compared to December 31,2009. The company also improved its balance sheet in 2010 by increasingassets to $9.8 million, a nearly tenfold increase from 2009. Biosignexpects to complete its manufacturing ramp-up by the third quarter of2011